Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe adverse event
affecting patients with cancer and patients with osteoporosis who have been treated with …

It is well established that alterations in phosphate metabolism have a profound effect on
hard and soft tissues of the oral cavity. The present-day clinical form of osteonecrosis of the …

Rice rats (Oryzomys palustris) are an unconventional laboratory species that has been used
to study photoperiodicity, periodontitis, and osteonecrosis of the jaw. Interventional …

Introduction Osteonecrosis of the jaw (ONJ) is an adverse event that requires association of
both systemic risk factors, such as powerful anti-resorptives (pARs; eg zoledronic acid …

Objective Investigate role of dose/duration of zoledronic acid (ZOL), a powerful anti-
resorptive (pAR), on prevalence of medication-related osteonecrosis of the jaw (MRONJ) in …

Objectives To determine the extent that zoledronate (ZOL) dose and duration is associated
with bisphosphonate‐related osteonecrosis of the jaw (BRONJ) prevalence in rice rats with …

The prevalence of periodontal diseases is increasing, tends to increase with age and is
considered as one of the main causes of tooth loss. To assess the effectiveness of new …

Abstract Objective Angiogenesis inhibitors (AgI) are commonly used in combination
chemotherapy protocols to treat cancer, and have been linked to osteonecrosis of the jaw …

Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe adverse event
in patients treated with antiresorptives. Management of MRONJ is challenging, and no non …

Periodontal disease (PD) is an infectious-inflammatory oral disease that is highly prevalent
among adolescence and adulthood and can lead to chronic orofacial pain and be …